TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the time course of changes in laboratory biomarkers in patients with rheumatoid arthritis (RA) 2, 4, and 8 weeks after the initiation of tocilizumab (TCZ) therapy. Subjects and methods. Forty-two RA patients receiving two intravenous infusions of TCZ (8 mg/kg each) at a 4-week in...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	E N Aleksandrova, E Yu Panasyuk, A S Avdeyeva, A A Novikov, G V Lukina, M V Cherkasova, N V Klimova, E L Nasonov
التنسيق:	مقال
اللغة:	Russian
منشور في:	IMA PRESS LLC 2011-06-01
سلاسل:	Научно-практическая ревматология
الموضوعات:	rheumatoid arthritis, interleukin-6 interleukin-6 receptors tocilizumab, erythrocyte sedimentation rate c-reactive protein, igm/iga rheumatoid factor anti-cyclic citrullinated peptide antibodies anti-modified citrullinated vimentin antibodies
الوصول للمادة أونلاين:	https://rsp.mediar-press.net/rsp/article/view/705

مواد مشابهة

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
حسب: Anastasia Sergeyevna Avdeyeva, وآخرون
منشور في: (2012-06-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
حسب: Anastasia Sergeyevna Avdeyeva, وآخرون
منشور في: (2013-06-01)

THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
حسب: Elena Nikolayevna Aleksandrova, وآخرون
منشور في: (2012-02-01)

DIAGNOSTIC MARKERS AND CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING DMARDS
حسب: Maria Sergeevna Voronina, وآخرون
منشور في: (2012-10-01)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
حسب: Somayye Norouzi, وآخرون
منشور في: (2020-08-01)

New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)
حسب: Evgeniy L'vovich Nasonov, وآخرون
منشور في: (2010-05-01)

Correlation between anti-mutated citrullinated vimentin and bone turnover markers (CTX-1 and P1NP) in patients with rheumatoid arthritis in remission and low-disease activity
حسب: Tulus Widiyanto, وآخرون
منشور في: (2022-08-01)

Methotrexate-induced changes in the concentration of antibodies to modified citrulnated vimentin in blood serum of patients with rheumatoid arthritis
حسب: Natal'ya Petrovna Shilkina, وآخرون
منشور في: (2011-05-01)

Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis
حسب: Liming Tan, وآخرون
منشور في: (2023-12-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
حسب: Nicole H. Trier, وآخرون
منشور في: (2019-06-01)

Assessment of the Correlation between Disease Activity and Serum Biomarker Anti-MCV and IL6 in Iraqi Patients with Rheumatoid Arthritis
حسب: Dania A. Ali, وآخرون
منشور في: (2024-10-01)

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
حسب: N. V. Bunchuk
منشور في: (2023-01-01)

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
حسب: E N Aleksandrova, وآخرون
منشور في: (2004-12-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
حسب: Nicole H. Trier, وآخرون
منشور في: (2017-03-01)

Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis
حسب: Akio Umemoto, وآخرون
منشور في: (2023-02-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
حسب: Hui-Chun Yu, وآخرون
منشور في: (2019-01-01)

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
حسب: Ilaria Fanelli, وآخرون
منشور في: (2021-07-01)

Antibodies against citrullinated proteins in relation to periodontitis with or without rheumatoid arthritis: a cross-sectional study
حسب: Pit Hui Lew, وآخرون
منشور في: (2021-07-01)

Different clinical relevance of anti-citrullinated proteins antibodies in RA patients
حسب: A. S. Avdeeva, وآخرون
منشور في: (2022-05-01)

INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES
حسب: E. L. Nasonov, وآخرون
منشور في: (2018-01-01)

Tocilizumab (Actemra)
حسب: Martin Sheppard, وآخرون
منشور في: (2017-09-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
حسب: Hisakata Yamada, وآخرون
منشور في: (2020-04-01)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
حسب: Alireza Sadeghi, وآخرون
منشور في: (2017-04-01)

Type-III interferons and rheumatoid arthritis: Correlation between interferon lambda 1 (interleukin 29) and antimutated citrullinated vimentin antibody levels
حسب: Diana Castillo-Martínez, وآخرون
منشور في: (2017-02-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
حسب: S.L.E. Ribeiro, وآخرون
منشور في: (2008-11-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
حسب: V. V. Badokin, وآخرون
منشور في: (2011-06-01)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
حسب: Marino Paroli, وآخرون
منشور في: (2023-10-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
حسب: Damjanovska Ljubinka, وآخرون
منشور في: (2007-01-01)

INVESTIGATION OF CANDIDATE GENE POLYMORPHISMS IN AN IMMUNE RESPONSE AS MARKERS FOR THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS AND PRODUCING AUTOANTIBODIES
حسب: I. A. Guseva, وآخرون
منشور في: (2016-03-01)

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS
حسب: E. L. Nasonov
منشور في: (2017-04-01)

The clinical aspect of overweight on rheumatoid arthritis and disease activity
حسب: Haitham Ahmed, وآخرون
منشور في: (2019-06-01)

Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
حسب: Lakshmi Deepika Yarlagadda, وآخرون
منشور في: (2020-01-01)

Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis
حسب: Alessandra Zaccardelli, وآخرون
منشور في: (2019-11-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
حسب: N. V. Rebrova, وآخرون
منشور في: (2022-07-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
حسب: E Yu Panasyuk, وآخرون
منشور في: (2011-08-01)

THE CLINICAL AND DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN EARLY JUVENILEARTHRITIS
حسب: S O Salugina, وآخرون
منشور في: (2009-06-01)

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis
حسب: Noriyoshi Ogawa, وآخرون
منشور في: (2019-01-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies, adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis
حسب: Mehanović-Nikolić Jasminka, وآخرون
منشور في: (2008-01-01)

An assessment of anti-citrullinated protein antibody in systemically healthy individuals with or without chronic periodontitis: A case–control study
حسب: Ankita Rajaram Yadav, وآخرون
منشور في: (2020-01-01)

DIAGNOSTIC VALUE OF ANTI-PEPTIDYLARGININE DEIMINASE TYPE 4 (PADI-4) AND ANTI- CITRULLINATED PEPTIDE ANTIBODIES (ACCP) IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS
حسب: Hassan J Hasony, وآخرون
منشور في: (2014-06-01)